176 related articles for article (PubMed ID: 21455861)
1. Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?
Franchini M; Lippi G
Semin Thromb Hemost; 2011 Apr; 37(3):275-9. PubMed ID: 21455861
[TBL] [Abstract][Full Text] [Related]
2. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilia in pregnancy.
Tan JY
Ann Acad Med Singap; 2002 May; 31(3):328-34. PubMed ID: 12061293
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden mutation and pregnancy-related complications.
Kjellberg U; van Rooijen M; Bremme K; Hellgren M
Am J Obstet Gynecol; 2010 Nov; 203(5):469.e1-8. PubMed ID: 21055512
[TBL] [Abstract][Full Text] [Related]
5. The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank.
Lo Faro V; Johansson T; Johansson Å
Am J Obstet Gynecol; 2024 Mar; 230(3):360.e1-360.e13. PubMed ID: 37734636
[TBL] [Abstract][Full Text] [Related]
6. The role of factor V Leiden in maternal health and the outcome of pregnancy.
Calderwood CJ; Greer IA
Curr Drug Targets; 2005 Aug; 6(5):567-76. PubMed ID: 16026277
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
Couto E; Nomura ML; Barini R; Pinto e Silva JL
Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
[TBL] [Abstract][Full Text] [Related]
8. Incidence of venous thromboembolism in families with inherited thrombophilia.
Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
[TBL] [Abstract][Full Text] [Related]
9. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
[TBL] [Abstract][Full Text] [Related]
11. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.
Rodger MA; Betancourt MT; Clark P; Lindqvist PG; Dizon-Townson D; Said J; Seligsohn U; Carrier M; Salomon O; Greer IA
PLoS Med; 2010 Jun; 7(6):e1000292. PubMed ID: 20563311
[TBL] [Abstract][Full Text] [Related]
12. Family history of venous thromboembolism and identifying factor V Leiden carriers during pregnancy.
Horton AL; Momirova V; Dizon-Townson D; Wenstrom K; Wendel G; Samuels P; Sibai B; Spong CY; Cotroneo M; Sorokin Y; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ;
Obstet Gynecol; 2010 Mar; 115(3):521-525. PubMed ID: 20177282
[TBL] [Abstract][Full Text] [Related]
13. Inherited thrombophilias and adverse pregnancy outcomes: a review of screening patterns and recommendations.
Davenport WB; Kutteh WH
Obstet Gynecol Clin North Am; 2014 Mar; 41(1):133-44. PubMed ID: 24491988
[TBL] [Abstract][Full Text] [Related]
14. Thrombophilias in pregnancy.
Battinelli EM; Bauer KA
Hematol Oncol Clin North Am; 2011 Apr; 25(2):323-33, viii. PubMed ID: 21444033
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
17. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
Herman M; Djelmis J; Troselj Z; Ivanisević M
Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
[TBL] [Abstract][Full Text] [Related]
18. The impact of the factor V Leiden mutation on pregnancy.
Spina V; Aleandri V; Morini F
Hum Reprod Update; 2000; 6(3):301-6. PubMed ID: 10874575
[TBL] [Abstract][Full Text] [Related]
19. The effect of factor V Leiden carriage on maternal and fetal health.
Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
[TBL] [Abstract][Full Text] [Related]
20. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
